Form 4: NeueHealth Acquired, NEA Entities Shift Ownership
Merger-Related Ownership Change
New Enterprise Associates 17, L.P. and related entities report the disposition of all NeueHealth, Inc. securities following its acquisition by NH Holdings 2025, Inc.
Summary
- New Enterprise Associates 17, L.P., NEA Partners 17, L.P., and NEA 17 GP, LLC reported significant changes in their beneficial ownership of NeueHealth, Inc. securities.
- On October 2, 2025, NeueHealth, Inc. completed a merger, becoming a wholly-owned subsidiary of NH Holdings 2025, Inc. (referred to as 'Parent').
- As part of the merger, the reporting persons contributed all their Common Stock, Series A Convertible Perpetual Preferred Stock, and Series B Convertible Perpetual Preferred Stock in NeueHealth, Inc. to NH Holdings 2025 SPV, L.P. ('Ultimate Parent') in exchange for limited partnership interests.
- Following this contribution, all their shares in NeueHealth, Inc. were cancelled, resulting in zero beneficial ownership in the issuer.
- Prior to the merger, on October 2, 2025, the reporting persons engaged in cashless net exercises of warrants, disposing of 280 shares and 276 shares of common stock at a fair market value of $6.75 per share.
- They also acquired 189,195 shares and 186,128 shares of common stock upon warrant exercise at an exercise price of $0.01 per share on the same date.
Sentiment
Score: 7
Explanation: The filing reports the completion of a merger where NeueHealth, Inc. became a wholly-owned subsidiary. The reporting persons, significant owners and directors, exchanged their securities for limited partnership interests in the ultimate parent, indicating a strategic transition rather than a divestment. This corporate action generally implies a move towards long-term value creation under new ownership.
Positives
- The reporting persons, who were significant investors and directors, maintained an interest in the underlying business by receiving limited partnership interests in the ultimate parent company post-merger.
- The merger provides a clear exit for public shareholders and potentially a more stable, private environment for NeueHealth, Inc.'s operations.
Negatives
- The reporting persons no longer hold direct beneficial ownership in NeueHealth, Inc. common stock or preferred stock.
- Public shareholders of NeueHealth, Inc. would have had their shares cancelled or converted as part of the merger, ceasing to be shareholders of the publicly traded entity.
Future Outlook
The filing indicates NeueHealth, Inc. is now a wholly-owned subsidiary of NH Holdings 2025, Inc., suggesting a new strategic direction and operational framework under the new parent company. No specific forward-looking statements beyond the merger's completion are provided.
Industry Context
The acquisition of a publicly traded company by a private entity or a newly formed holding company is a common strategy for restructuring, taking a company private, or integrating it into a larger portfolio. This move suggests a significant shift in NeueHealth's operational and financial oversight, potentially aiming for long-term value creation outside public market pressures.
Comparison to Industry Standards
- This filing reports a standard change in beneficial ownership following a corporate merger.
- Specific financial terms of the merger, such as valuation multiples or premiums, are not disclosed, preventing direct comparison to industry M&A benchmarks.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Ownership Structure | NeueHealth, Inc. transitioned from a publicly traded company to a wholly-owned subsidiary of NH Holdings 2025, Inc. | 10/02/2025 | This fundamentally alters the corporate governance framework, shifting decision-making authority and oversight from a public board accountable to shareholders to a privately controlled entity. |
Related Party Transactions
- The reporting persons (New Enterprise Associates 17, L.P., NEA Partners 17, L.P., and NEA 17 GP, LLC), identified as directors and 10% owners, contributed their NeueHealth, Inc. securities to NH Holdings 2025 SPV, L.P. (the 'Ultimate Parent') in exchange for limited partnership interests as part of the merger. This constitutes a related-party transaction.
Stakeholder Impact
- Shareholders: Public shareholders of NeueHealth, Inc. would have had their shares acquired or converted as part of the merger, ceasing to be shareholders of the publicly traded entity. The reporting persons, as major shareholders, received limited partnership interests in the ultimate parent.
- Employees, Customers, Suppliers, Creditors: The filing does not directly address the impact on these stakeholders, though a merger of this nature typically leads to organizational and operational changes.
Next Steps
- No specific future actions or milestones for NeueHealth, Inc. are mentioned in this filing, as it reports a completed corporate action. The reporting persons now hold limited partnership interests in the ultimate parent.
Key Dates
| Date | Description |
|---|---|
| 08/04/2023 | Original date of the Credit Agreement. |
| 10/02/2023 | Date of Incremental Amendment No. 1 to the Credit Agreement. |
| 04/08/2024 | Date of Incremental Amendment No. 2 to the Credit Agreement. |
| 04/30/2024 | Warrants became exercisable as to 123,729 shares. |
| 06/21/2024 | Date of Amendment No. 3 to the Credit Agreement; Warrants became exercisable as to 1,733 shares. |
| 10/02/2024 | Warrants became exercisable as to 61,865 shares. |
| 10/29/2024 | Date of Amendment No. 4 to the Credit Agreement. |
| 12/23/2024 | Date of the Agreement and Plan of Merger. |
| 09/26/2025 | Warrants became exercisable as to 1,868 shares. |
| 09/30/2025 | Date of the Warrantholders Agreement and Amendment No. 5 to the Credit Agreement. |
| 10/01/2025 | Closing market price of NeueHealth, Inc. common stock was $6.75 per share. |
| 10/02/2025 | Date of earliest transaction reported; Merger effective date; Warrants became fully exercisable; Disposition of all securities by reporting persons. |
| 10/06/2025 | Signature date of the Form 4 filing. |
| 10/02/2030 | Expiration date of certain warrants. |
Keywords
NeueHealth, NEUE, Merger, Acquisition, SEC Form 4, Beneficial Ownership, New Enterprise Associates, Private Equity, Preferred Stock, Warrants, Corporate Action
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.